Lack of prognostic value of epidermal growth factor receptor in a series of 229 T1/T2, N0/N1 breast cancers, with well defined prognostic parameters
Autor: | Pasquier D, M.H. Panh, J. Marron-Charrière, Béatrice Rostaing-Puissant, Marc Colonna, Edmond M. Chambaz, Michel Bolla, M. Chedin, P. Winckel |
---|---|
Rok vydání: | 1994 |
Předmět: |
Oncology
Cancer Research medicine.medical_specialty Pathology Multivariate analysis Mammary gland Breast Neoplasms Breast cancer Epidermal growth factor Internal medicine medicine Humans Prospective Studies Epidermal growth factor receptor Lymph node Analysis of Variance Univariate analysis Epidermal Growth Factor biology business.industry Carcinoma Middle Aged Prognosis medicine.disease Combined Modality Therapy ErbB Receptors Survival Rate medicine.anatomical_structure biology.protein Female business Follow-Up Studies Cohort study |
Zdroj: | Breast Cancer Research and Treatment. 29:265-270 |
ISSN: | 1573-7217 0167-6806 |
DOI: | 10.1007/bf00666480 |
Popis: | The prognostic value of epidermal growth factor receptor (EGF-R) was prospectively assessed in a series of 229 clinical T1-T2, N0-N1 breast carcinomas diagnosed between May 1987 and October 1989. EGF-R expression was determined by measuring the specific Bmax of 125I EGF to tumor plasma membrane preparations. Tumor with a Bmaxor = 3 fmol/mg of protein were considered positive with regard to EGF-R expression. With a median follow-up of 34 months, the 3-year overall and disease-free survivals are respectively 92% and 88% for EGF-Ror = 3, and 91% and 86% EGF-R3 fmol, showing no significant difference, even when comparing axillary lymph node status. We did not succeed in finding an EGF-R cut-off value which might be significant in univariate analysis. Multivariate analysis of our data indicates that pT (p = 0.001), pN (p = 0.04), and Scarff-Bloom grade (p = 0.04) are the only significant predictors of disease-free survival among the parameters investigated in this study. |
Databáze: | OpenAIRE |
Externí odkaz: |